Magnetic brain zaps may flush out Alzheimer's proteins

NCT ID NCT07192913

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique, can improve the brain's natural waste-clearing system (glymphatic function) in people with mild cognitive impairment. Researchers will give TMS to 20 participants to see if it helps remove amyloid and tau proteins linked to Alzheimer's disease. The goal is to understand if this approach could slow disease progression.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Transcranial Magnetic Stimulation (TMS)
What this could lead to
If it works, this could point toward a non-invasive way to help the brain clear harmful proteins linked to Alzheimer's disease.
What could go wrong
This is a very small early-phase trial with only 20 people, so results may not apply widely. It is testing a mechanism, not a proven treatment, and may show no benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.